Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · IEX Real-Time Price · USD
56.12
-0.81 (-1.42%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Legend Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-518.25-446.35-403.58-266.37-101.59-2.78
Depreciation & Amortization
20.4518.3913.929.935.261.67
Share-Based Compensation
47.6834.3420.164.761.270.7
Other Operating Activities
10.66183.58169.9818.3918.62306.37
Operating Cash Flow
-439.47-210.04-199.53-233.29-76.43305.96
Capital Expenditures
-20.93-42.190-26.25-26.7-20.94
Acquisitions
-14.81-1.710-19.4938.13-75
Change in Investments
-40.01-147.88025.61-69.55-6.26
Other Investing Activities
-1.35-3.21--4.03-0.53-0.06
Investing Cash Flow
-77.09-194.980-24.17-58.65-102.26
Share Issuance / Repurchase
380.57628.080463.5500
Debt Issued / Paid
-2.6-1.420-2.6114.672.5
Other Financing Activities
---157.94--
Financing Cash Flow
377.98626.660618.8814.672.5
Exchange Rate Effect
0.68-2.510.030.620.250.12
Net Cash Flow
49199.6233.22371.71-127.05207.93
Free Cash Flow
-460.39-252.24-199.53-259.54-103.13285.02
Free Cash Flow Margin
-161.46%-215.58%-289.91%-346.06%-171.95%580.10%
Free Cash Flow Per Share
-2.62-1.59-1.42-2.20-1.03-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).